Koyfin Home > Directory > Health Care > Amphastar Pharma > Net Debt / (EBITDA-CAPEX)

Amphastar Pharma Net Debt / (EBITDA-CAPEX) Chart (AMPH)

Amphastar Pharma annual/quarterly Net Debt / (EBITDA-CAPEX) from 2003 to 2018.
  • Amphastar Pharma Net Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2018 was $0m
Other Ratios Metrics:
  • Amphastar Pharma Total Debt / Capital for the quarter ending December 12, 2018 was $12m a -1.34% decrease of 0m year over year
  • Amphastar Pharma Other Liabilities for the quarter ending December 12, 2018 was $10m a -0.42% decrease of 0m year over year
  • Amphastar Pharma Total Debt / Equity for the quarter ending December 12, 2018 was $14m a -1.53% decrease of 0m year over year
View Chart On Koyfin

Quarterly AMPH Net Debt / (EBITDA-CAPEX) Data

06/2018$0m
12/2003$19m